Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ethical considerations in conducting pediatric research.
Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM. Roth-Cline M, et al. Among authors: gerson j. Handb Exp Pharmacol. 2011;205:219-44. doi: 10.1007/978-3-642-20195-0_11. Handb Exp Pharmacol. 2011. PMID: 21882114
Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework [Internet].
Goodman SN, Gerson J. Goodman SN, et al. Among authors: gerson j. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun. Report No.: 13-EHC042-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun. Report No.: 13-EHC042-EF. PMID: 24027800 Free Books & Documents. Review.
Development of National Research and Clinical Agendas for Patient-Reported Outcomes in IR: Proceedings from a Multidisciplinary Consensus Panel.
Kwan SW, Charalel RA, Stover AM, Baumhauer JF, Cella D, Darien G, Durack JC, Gerson J, Opelka F, Patrick DL, Salem R, Spies JB, Wu AW, White SB. Kwan SW, et al. Among authors: gerson j. J Vasc Interv Radiol. 2018 Jan;29(1):1-8. doi: 10.1016/j.jvir.2017.08.027. Epub 2017 Nov 21. J Vasc Interv Radiol. 2018. PMID: 29169781 No abstract available.
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.
Shah NN, Wang M, Roeker LE, Patel K, Woyach JA, Wierda WG, Ujjani CS, Eyre TA, Zinzani PL, Alencar AJ, Ghia P, Lamanna N, Hoffmann MS, Patel MR, Flinn I, Gerson JN, Ma S, Coombs CC, Cheah CY, Lech-Maranda E, Fakhri B, Kim WS, Barve MA, Cohen JB, Jurczak W, Munir T, Thompson MC, Tsai DE, Bao K, Cangemi NA, Kherani JF, Walgren RA, Han H, Ruppert AS, Brown JR. Shah NN, et al. Among authors: gerson jn. Haematologica. 2025 Jan 1;110(1):92-102. doi: 10.3324/haematol.2024.285754. Haematologica. 2025. PMID: 39363864 Free PMC article. Clinical Trial.
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia.
Chong EA, Kumashie KG, Chong ER, Fabrizio J, Gupta A, Svoboda J, Barta SK, Walsh KM, Napier EB, Lundberg RK, Nasta SD, Gerson JN, Landsburg DJ, Gonzalez J, Gaano A, Weirick ME, McAllister CM, Awofolaju M, John GN, Kammerman SC, Novacek J, Pajarillo R, Lundgreen KA, Tanenbaum N, Gouma S, Drapeau EM, Adamski S, D'Andrea K, Pattekar A, Hicks A, Korte S, Sharma H, Herring S, Williams JC, Hamilton JT, Bates P, Hensley SE, Prak ETL, Greenplate AR, Wherry EJ, Schuster SJ, Ruella M, Vella LA. Chong EA, et al. Among authors: gerson jn. J Infect Dis. 2024 Jul 25;230(1):15-27. doi: 10.1093/infdis/jiae106. J Infect Dis. 2024. PMID: 39052709
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.
Gioia N, Gerson J, Ryan R, Barbour K, Poteet J, Jennings B, Sharp M, Lowery R, Wilson J, Morde A, Rai D, Padigaru M, Periman LM. Gioia N, et al. Among authors: gerson j. Front Ophthalmol (Lausanne). 2024 Apr 24;4:1362113. doi: 10.3389/fopht.2024.1362113. eCollection 2024. Front Ophthalmol (Lausanne). 2024. PMID: 38984118 Free PMC article.
182 results